Raids conducted in Punjab State by FDA to check the illegal sale of Habit-Forming Drugs

The statewide raids were made by the Punjab state’s Food and Drug Administration and the results are very disappointed as many of the chemists were selling habit-forming drugs without any prescription illegally.

FDA team found Chemists were confiscated a large number of abused drugs and collected samples of the medicines for quality check. FDA officials also seized 10 lakhs worth of Alprazolam and Propranolol drug worth Rs 3.9 lakh from chemist Maruti Pharma in Muktsar.

The chemist was failed to show any bill for these stored stock. Cardilax-Alprazolam and propranolol tablets worth Rs 1 lakh were seized from another chemist Rinku Pharma.

Team also collected samples from various districts like Bathinda, Fazilka, Ludhiana and SBS Nagar. The team will send these samples to the government laboratory for quality check. Raid results again proved that there is a need to take strong action among them as drug consumption is increasing day by day in the state.

These kind of activities are becoming the reasons for the slow killing of a youth and that will be putting their future to the dark. Many small courier companies are also involved in transferring these habit-forming drugs such as buprenorphine and pain reliever tramadol. Smugglers also using public transport like AC buses and trains to smuggle these drugs to earn bucks of money.

The Punjab state has also initiated interstate coordination with neighboring states to check the menace.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit